BRIEF-Halozyme Therapeutics Outlook FY Revenue USD 1,385-1,400 Million

Halozyme Therapeutics, Inc. +0.05%

Halozyme Therapeutics, Inc.

HALO

63.59

+0.05%

Feb 17 (Reuters) - Halozyme Therapeutics Outlook FY revenue USD 1,385-1,400 million.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via